HOLX - Hologic, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
41.98
-1.27 (-2.94%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close43.25
Open43.30
Bid42.07 x 100
Ask45.17 x 100
Day's Range41.92 - 43.40
52 Week Range35.10 - 45.17
Volume2,288,727
Avg. Volume2,093,044
Market Cap12.141B
Beta (3Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-0.41
Earnings DateFeb 6, 2019 - Feb 11, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est45.09
Trade prices are not sourced from all markets
  • Hologic Launches Three-in-One Omni™ Hysteroscope
    Business Wire22 minutes ago

    Hologic Launches Three-in-One Omni™ Hysteroscope

    Flexible, modular design with powerful visualization gives doctors a single device with three sheath options to both diagnose and treat patients

  • How Hologic Stock Has Fared in the Last Month
    Market Realist4 days ago

    How Hologic Stock Has Fared in the Last Month

    After rising from $36.53 on April 9, 2018, to $42.91 on July 31, 2018, Hologic (HOLX) stock slid to $37.90 on October 29, 2018. Subsequently, Hologic stock managed to rise to $44.51 on November 28, 2018. Hologic’s revenue grew by 1.32% from $802.9 million in the fourth quarter of 2017 to $813.5 million in the fourth quarter of 2018.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit6 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • 3 Big Stock Charts for Friday: Hologic, Newell Brands and Juniper Networks
    InvestorPlace10 days ago

    3 Big Stock Charts for Friday: Hologic, Newell Brands and Juniper Networks

    The 2.6% advance from General Electric (NYSE:GE) shares on Thursday still wasn’t enough to get, and keep, the overall market out of the red. Although the index spent some time in profitable territory yesterday, by the time the closing bell rang the S&P 500 was down to the tune of 0.22%. Rather than GE, a few too many traders were taking their cues from Twitter (NYSE:TWTR) and Quest Diagnostics (NYSE:DGX).

  • Analysts Remain Bullish on Align Stock
    Market Realist11 days ago

    Analysts Remain Bullish on Align Stock

    In November 2018, of the total 15 analysts covering Align Technology (ALGN), 13 analysts have given Align stock a “buy” or higher rating, and two analysts have given it a “hold” rating. The mean rating for Align Technology stock is 1.67 with a target price of $317.36, implying an upside potential of 43.8% over Align Technology’s closing price of $220.71 on November 27, 2018.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit13 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • What Analysts Recommend for Hologic Stock
    Market Realist14 days ago

    What Analysts Recommend for Hologic Stock

    In November 2018, of the total 20 analysts covering Hologic (HOLX), ten analysts have given the stock a “buy” or higher rating, and ten analysts have given it a “hold” rating. The mean rating for Hologic stock is 2.3 with a target price of $45.09, implying an upside potential of 8.5% over Hologic’s closing price of $41.54 on November 21, 2018.

  • How Does Hologic’s Operational Performance Look?
    Market Realist14 days ago

    How Does Hologic’s Operational Performance Look?

    Hologic (HOLX) incurred general and administrative expenses of $366.1 million in fiscal 2018 as compared with $343.3 million in fiscal 2017. This increase was due to higher legal fees, costs for international infrastructure, and higher bad debt. Its selling and marketing expenses also increased from $498.6 million in fiscal 2017 to $544.6 million in fiscal 2018 due to Cynosure’s inclusion in Hologic’s activity.

  • A Look at Hologic’s Gross Margin Trend
    Market Realist14 days ago

    A Look at Hologic’s Gross Margin Trend

    Hologic’s (HOLX) cost of product revenues increased from $881.8 million in fiscal 2017 to $886.6 million in fiscal 2018. Its amortization on intangible assets increased from $297.1 million in fiscal 2017 to $319.4 million in fiscal 2018 due to an increase associated with the Cynosure acquisition partially offset by lower amortization expenses related to the sale of its blood screening business. The company’s gross margin contracted from 64.07% in fiscal 2017 to 62.72% in fiscal 2018.

  • How Hologic’s Revenue Is Trending
    Market Realist14 days ago

    How Hologic’s Revenue Is Trending

    Hologic (HOLX) is a leading developer, manufacturer, and supplier of diagnostics products, medical imaging systems, surgical products, and treatment systems. The company operates in five segments: diagnostics, breast health, medical aesthetics, GYN surgical, and skeletal health.

  • Business Wire17 days ago

    Hologic to Showcase Growing Portfolio of Breast and Skeletal Health Innovations at RSNA 2018

    Hologic, Inc. (HOLX) will showcase its expanding suite of breast and skeletal health products, including screening, interventional, ultrasound and surgical solutions, in Booth #2511 at the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place in Chicago from Nov. 25 to 29. The pioneer behind the Genius™ 3D Mammography™ exam, Hologic has expanded significantly in recent years to offer innovations across the entire clinical continuum of breast health. In addition, two recent acquisitions of Faxitron® Bioptics, a leader in digital specimen radiography, and Focal Therapeutics, manufacturer of the BioZorb® marker, have enabled Hologic to play a larger role in breast conserving surgery and strengthened its offerings to radiologists, pathologists and breast surgeons.

  • Ludwig N. Hantson Elected to Hologic Board of Directors
    Business Wire21 days ago

    Ludwig N. Hantson Elected to Hologic Board of Directors

    Hologic, Inc. (HOLX) announced today that Ludwig N. Hantson has been elected to the Company’s Board of Directors, effective immediately. Dr. Hantson, who has more than 30 years of experience in the life sciences industry, is the Chief Executive Officer of Alexion Pharmaceuticals, Inc., a publicly-traded global biopharmaceutical company. Before joining Alexion, Dr. Hantson was President and Chief Executive Officer of Baxalta Incorporated.

  • Business Wire24 days ago

    Hologic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference

    Hologic, Inc. announced today that the Company will present at the 30th Annual Piper Jaffray Healthcare Conference in New York, NY on Wednesday, November 28 at 8 a.m.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of HOLX earnings conference call or presentation 7-Nov-18 9:30pm GMT

    Q4 2018 Hologic Inc Earnings Call

  • Hologic (HOLX) Q4 Earnings Miss, Revenues Top Estimates
    Zackslast month

    Hologic (HOLX) Q4 Earnings Miss, Revenues Top Estimates

    Tough year-over-year comparisons and soft Diagnostics sales hurt Hologic's (HOLX) performance in Q4.

  • Hologic, Inc. (HOLX) Q4 2018 Earnings Conference Call Transcript
    Motley Foollast month

    Hologic, Inc. (HOLX) Q4 2018 Earnings Conference Call Transcript

    HOLX earnings call for the period ending September 30, 2018.

  • Hologic (HOLX) Misses Q4 Earnings Estimates
    Zackslast month

    Hologic (HOLX) Misses Q4 Earnings Estimates

    Hologic (HOLX) delivered earnings and revenue surprises of -1.69% and 1.04%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Presslast month

    Hologic: Fiscal 4Q Earnings Snapshot

    MARLBOROUGH, Mass. (AP) _ Hologic Inc. (HOLX) on Wednesday reported fiscal fourth-quarter profit of $50.5 million. The Marlborough, Massachusetts-based company said it had profit of 18 cents per share. The results fell short of Wall Street expectations.

  • Business Wirelast month

    Hologic Announces Financial Results for Fourth Quarter of Fiscal 2018

    – Revenue of $813.5 Million Grows 1.3%, 1.7% in Constant Currency –

  • Business Wirelast month

    Hologic to Webcast Presentation at the Stifel 2018 Healthcare Conference

    Hologic, Inc. announced today that the Company will present at the Stifel 2018 Healthcare Conference in New York, NY on Tuesday, November 13 at 8 a.m. Eastern Time.